论文部分内容阅读
目的:探讨与研究长春西汀联合依达拉奉治疗急性脑出血的临床疗效和价值。方法:将我院收治的急性脑出血患者分为观察组和对照组,对照组在常规治疗的基础上给予依达拉奉静脉滴注,观察组在常规治疗的基础上采用长春西汀联合依达拉奉治疗,观察并比较两组患者治疗效果、血肿量、神经功能损失情况及日常活动能力评分。结果:观察组患者的治疗效果及日常活动能力均优于对照组,血肿量及神经功能损失情况均低于对照组,差别均具有统计学意义(P<0.05)。结论:将长春西汀联合依达拉奉应用于治疗急性脑出血中,具有积极意义,值得临床推广。
Objective: To investigate and study the clinical efficacy and value of vinpocetine combined with edaravone in the treatment of acute cerebral hemorrhage. Methods: Acute cerebral hemorrhage patients admitted to our hospital were divided into observation group and control group. The control group was given intravenous edaravone on the basis of routine treatment. The observation group was treated with vinpocetine combined with Da Vinci treatment, observation and comparison of the two groups of patients treatment, hematoma volume, loss of nerve function and daily activity score. Results: The therapeutic effects and daily activities of patients in the observation group were better than those in the control group. The hematoma volume and nerve function loss were lower in the observation group than in the control group, with statistical significance (P <0.05). Conclusion: The combination of vinpocetine and edaravone in the treatment of acute intracerebral hemorrhage has a positive meaning and is worthy of clinical promotion.